PolyActiva
Develops ocular implants for sustained drug release
PolyActiva is a Melbourne-based biotech company that specializes in developing ocular therapeutic products. Their work focuses on creating biodegradable materials for ocular implants, with the aim of providing sustained release of drugs for the treatment of eye conditions.
The firm utilizes proprietary polymer prodrug technology to create these implants. The technology enables the drug to be linked directly to the polymer chain, allowing for controlled and sustained drug release. The company's current projects include treatments for glaucoma, uveitis, and macular degeneration.